Shareholders of innoscripta SE approved a dividend of €4.00 per share for the 2025 financial year at the company’s Annual General Meeting, with all agenda items adopted by a strong majority exceeding 97.6%. The meeting also resulted in the re-election of three supervisory board members whose combined expertise in capital markets, finance, and international corporate development positions the company to advance its capital markets strategy and pursue further international growth.
Philipp von Ilberg, Stefan Berndt-von Bülow, and Dr. Erik Massmann were re-elected to the Supervisory Board. Von Ilberg serves as Chairman of the Supervisory Board of CompuGroup SE & Co. KGaA and brings extensive experience in complex corporate and capital markets transactions. Berndt-von Bülow has substantial CFO experience in listed technology companies and has successfully led transactions including a NASDAQ IPO. Massmann most recently served as CFO of the Birkenstock Group and was responsible for its IPO on the NYSE along with numerous international finance and transformation projects.
Shareholders additionally approved the relocation of the company’s registered seat from Munich to Tutzing, a move that has already been implemented. This establishes a clearer organizational structure with key central functions consolidated at the new headquarters, while operational units remain in Munich, Cologne, and Frankfurt. The relocation strengthens the efficiency of the group structure, provides meaningful economic benefits from a fiscal perspective, and creates a solid foundation for further growth, particularly in international markets.
A total of 91.7% of the share capital was represented at the Annual General Meeting. The full voting results are available in the Investors section of the company’s website at https://www.innoscripta.com/en/investoren/hauptversammlung-2026.
This news story relied on content distributed by NewMediaWire. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Innoscripta Shareholders Approve Dividend and Confirm Supervisory Board with Capital Markets Expertise.